These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11869692)

  • 1. Treatment of Helicobacter pylori infection in patients with peptic ulcer disease.
    Godshall CJ
    Am J Surg; 2002 Jan; 183(1):2-3. PubMed ID: 11869692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Helicobacter pylori infections in gastric and duodenal ulcers].
    Svestka T
    Cas Lek Cesk; 2003 Aug; 142(8):483-6. PubMed ID: 14626564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of H. pylori eradication.
    Roesch W
    J Physiol Pharmacol; 1996 Mar; 47(1):71-7. PubMed ID: 8777309
    [No Abstract]   [Full Text] [Related]  

  • 4. H pylori in patients with peptic ulcer disease.
    Strickland C
    J Fam Pract; 1998 Feb; 46(2):117. PubMed ID: 9487314
    [No Abstract]   [Full Text] [Related]  

  • 5. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
    MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
    [No Abstract]   [Full Text] [Related]  

  • 6. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
    Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
    Ford AC; Delaney BC; Forman D; Moayyedi P
    Am J Gastroenterol; 2004 Sep; 99(9):1833-55. PubMed ID: 15330927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Farmacoeconomical estimation of efficiency of different schemes of eradication therapy of Helicobacter pylori infection in children].
    Kashnikova SN; Shcherbakov PL; Kashnikov VV; Tatarinov PA; Shcherbakova MIu
    Eksp Klin Gastroenterol; 2008; (7):111-8. PubMed ID: 19334454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
    Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
    Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Helicobacter pylori infection.
    Vakil N
    Am J Ther; 1998 May; 5(3):197-201. PubMed ID: 10099059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication.
    Agro K; Blackhouse G; Goeree R; Willan AR; Huang JQ; Hunt RH; O'Brien BJ
    Pharmacoeconomics; 2001; 19(8):831-43. PubMed ID: 11596835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases].
    Samsonov AA; Grechushnikov VB; Andreev DN; Iurenev GL; Korovina TI; Lezhneva IuA; Maev IV
    Ter Arkh; 2014; 86(8):56-61. PubMed ID: 25306745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and peptic ulcer disease. Bridging the gap between knowledge and treatment.
    Laine L; Fendrick AM
    Postgrad Med; 1998 Mar; 103(3):231-8, 243. PubMed ID: 9519040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and peptic ulcer.
    Korman MG; Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indication for the treatment of Helicobacter pylori infection].
    Svestka T; Krechler T; Brůha R; Jablonská M
    Cas Lek Cesk; 2004; 143(12):850-3. PubMed ID: 15730218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
    Grinevich VB; Sablin OA; Gubonina IV; Dobrenko VA
    Eksp Klin Gastroenterol; 2005; (2):95-9. PubMed ID: 15932163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.